Skip to content

Evaluating The Effect Of Rukshana and Vasti Therapy in the management Of Ankylosing Spondylitis.

Clinical Evaluation Of Comprehensive Ayurveda Treatment Protocol In The Management Of Ankylosing Spondylitis. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086018
Enrollment
30
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M459- Ankylosing spondylitis of unspecified sites in spine

Interventions

None listed

Sponsors

Dr.BRKR Govt Ayurvedic Medical Collegee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient diagnosed with Ankylosing spondylitis based on clinical and radiological criteria. 2.Age between 18-65 yrs. 3.Willingness to undergo Ayurvedic Panchakarma therapy. 4.Willingness to provide informed consent. 5.Patient eligible for proposed treatment protocol i.e.Ruksha Pinda Sweda,Virechana,Vasti

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating mother. 2. Patient with severe comorbidities such as Uncontrolled Diabetes , Hypertesion or cardiac conditions. 3. History of aliergic reactions to components of Panchakarma therapy. 4. Patient undergoing immunosuppressive therapy or recent surgery. 5. Complications of Ankylosing Spondylitis with Extra Articular Manifestations. 6. Patient diagnosed with other joint disorders.

Design outcomes

Primary

MeasureTime frame
1.Reduction in Low back pain 2.Reduction of Inflammation 3.Improvement of Subjective parameters 4.Total improvement in quality of LifeTimepoint: 6 months

Secondary

MeasureTime frame
1. Improving quality of life 2. Decreasing disease progression in Ankylosing Spondylitis patients.Timepoint: 6 months

Countries

India

Contacts

Public ContactDrPraveen Kumar Madikonda

Dr BRKR Govt Ayurvedic Medical College

pkmadikonda@gmail.com9849271601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026